Zofenoprilat is a potent angiotensin-converting enzyme (ACE) inhibitor that serves as the active sulfhydryl metabolite of the prodrug zofenopril, primarily indicated for the treatment of hypertension and… Read more






Zofenoprilat is a potent angiotensin-converting enzyme (ACE) inhibitor that serves as the active sulfhydryl metabolite of the prodrug zofenopril, primarily indicated for the treatment of hypertension and angina pectoris. Analytical laboratories require high-quality reference standards of Zofenoprilat, its salts, and associated degradants to ensure the accuracy of pharmaceutical testing. This collection supports robust quality control and impurity profiling, offering essential tools for the identification and quantification of process-related impurities such as (R)-(1,3-Oxathiolan-2-yl)methyl benzoate and the Zofenoprilat N-ethyl succinimide adduct. Furthermore, stable isotope-labelled compounds, including Zofenoprilat-d5 and its labelled adducts, are critical for method validation and as internal standards in mass spectrometry-based assays. By utilizing these precise analytical materials, researchers can maintain stringent compliance with regulatory standards throughout the development and manufacturing life cycle of ACE inhibitor formulations.